Global trends in restenosis research within acute coronary syndrome: a bibliometric analysis

Z Boshanov1, A A Kaliyev, N M Mussin

  • 1Department of X-ray Surgery, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan. zhantilekboshanov@gmail.com.

Insights

Cardiovascular diseases (CVD) are a major global health concern. This study maps research on in-stent restenosis after percutaneous coronary intervention, identifying key contributors and trends.

Area of Science:

  • Cardiovascular Diseases
  • Interventional Cardiology
  • Bibliometric Analysis

Background:

  • Cardiovascular diseases (CVD) caused 32% of global deaths in 2019.
  • Percutaneous coronary interventions (PCI) like stenting treat coronary artery disease (CAD).
  • In-stent restenosis remains a challenge, leading to angina recurrence post-PCI.

Purpose of the Study:

  • To analyze the research landscape of in-stent restenosis.
  • To identify leading countries, institutions, authors, and keywords in this field.
  • To understand the global research trends and collaborations.

Main Methods:

  • Bibliometric analysis of publications.
  • Data sourced from Scopus and Web of Science Core Collection databases.
  • Utilized the Bibliometrix R-package for analysis.

Main Results:

  • Research shows a 6.82% annual growth rate.
  • China, Argentina, and Italy are leading countries in publications.
  • Capital Medical University and authors Kim J. and Yang C. are highly productive.
  • "In-stent restenosis" and "percutaneous coronary intervention" are key terms.

Conclusions:

  • Research is concentrated in developed nations, potentially limiting generalizability.
  • Developing countries show increasing interest in this research area.
  • The study highlights research gaps and future directions for in-stent restenosis studies.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.1K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
943
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522